These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6930702)

  • 21. Rapid induction of nuclear transcripts and inhibition of intron decay in response to the polymerase II inhibitor DRB.
    Clement JQ; Wilkinson MF
    J Mol Biol; 2000 Jun; 299(5):1179-91. PubMed ID: 10873444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic and biochemical studies on mutants of CHO cells resistant to 7-deazapurine nucleosides: differences in the mechanisms of action of toyocamycin and tubercidin.
    Gupta RS; Mehta KD
    Biochem Biophys Res Commun; 1984 Apr; 120(1):88-95. PubMed ID: 6712702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different populations of RNA polymerase II in living mammalian cells.
    Hieda M; Winstanley H; Maini P; Iborra FJ; Cook PR
    Chromosome Res; 2005; 13(2):135-44. PubMed ID: 15861303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on Chinese hamster ovary mutants showing multiple cross-resistance to oxidative phosphorylation inhibitors.
    Lagarde AE; Siminovitch L
    Somatic Cell Genet; 1979 Nov; 5(6):847-71. PubMed ID: 545726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel mutants of CHO cells resistant to adenosine analogs and containing biochemically altered form of adenosine kinase in cell extracts.
    Mehta KD; Gupta RS
    Somat Cell Mol Genet; 1986 Jan; 12(1):21-31. PubMed ID: 3003929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cycloheximide-resistance in Chinese hamster ovary cells and human fibroblast cells. Cytogenetic and biochemical characterization.
    Pöche H; Nierhaus KH; Zakrzewski S
    Hum Genet; 1979 Sep; 50(3):297-305. PubMed ID: 489015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of HeLa-S3 cell proliferation and biosynthesis by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB).
    Tamm I; Kikuchi T
    Proc Soc Exp Biol Med; 1983 Jun; 173(2):238-43. PubMed ID: 6191332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcription inhibition by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) causes DNA damage and triggers homologous recombination repair in mammalian cells.
    Stoimenov I; Gottipati P; Schultz N; Helleday T
    Mutat Res; 2011 Jan; 706(1-2):1-6. PubMed ID: 21074544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon induction with Newcastle disease virus in FS-4 cells: effect of 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB).
    Kohase M; Vilcek J
    Arch Virol; 1979; 62(3):263-71. PubMed ID: 518308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of premature termination of transcription of the mouse beta-globin gene by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB).
    Tweeten KA; Molloy GR
    Nucleic Acids Res; 1981 Jul; 9(14):3307-19. PubMed ID: 6269079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapidly phosphorylated histone-like proteins are modulated in the course of transcription block by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole.
    Egyházi E; Pigon A
    Eur J Cell Biol; 1983 Sep; 31(2):354-9. PubMed ID: 6641743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HeLa cell RNA and protein syntheses. Effects of long-term treatment with 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB).
    Tamm I
    Biochem Pharmacol; 1984 Feb; 33(4):551-7. PubMed ID: 6200120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulse and steady-state labelled and actinomycin D chased 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB)-resistant hnRNA from uninfected HeLa cells.
    Brysch B
    Acta Biochim Pol; 1983; 30(3-4):311-24. PubMed ID: 6201028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Codominant translational mutants of Chinese hamster ovary cells selected with diphtheria toxin.
    Moehring TJ; Danley DE; Moehring JM
    Somatic Cell Genet; 1979 Jul; 5(4):469-80. PubMed ID: 291128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early termination of heterogeneous nuclear RNA transcripts in mammalian cells: accentuation by 5,6-dichloro 1-beta-D-ribofuranosylbenzimidazole.
    Tamm I; Kikuchi T
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5750-4. PubMed ID: 293679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recovery of HeLa cell population growth after treatment with 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB).
    Tamm I
    J Cell Physiol; 1983 Jul; 116(1):26-34. PubMed ID: 6853610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutagenicity testing in mammalian cells. II. Validation of multiple drug-resistance markers having practical application for screening potential mutagens.
    Carver JH; Adair GM; Wandres DL
    Mutat Res; 1980 Sep; 72(2):207-30. PubMed ID: 6449664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-induced dispersal of transcribed rRNA genes and transcriptional products: immunolocalization and silver staining of different nucleolar components in rat cells treated with 5,6-dichloro-beta-D-ribofuranosylbenzimidazole.
    Scheer U; Hügle B; Hazan R; Rose KM
    J Cell Biol; 1984 Aug; 99(2):672-9. PubMed ID: 6204996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the diphtheria toxin-resistance system in Chinese hamster ovary cells.
    Moehring JM; Moehring TJ
    Somatic Cell Genet; 1979 Jul; 5(4):453-68. PubMed ID: 494060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole inhibits transcription of the beta-hemoglobin gene in vivo at initiation.
    Mukherjee R; Molloy GR
    J Biol Chem; 1987 Oct; 262(28):13697-705. PubMed ID: 3477544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.